Agreed; I probably wouldn’t have said “overwhelming evidence”. But I do think there are still large gains to be made by vaccinating against more diseases, like, say, strep.
Revelation: The point of diminishing returns we would (in an ideal reach) is where health benefits are proportional to research dollars. Once a vaccine is researched, health benefits should be positive. However, variation, like the variation between regions, means that there are cases where an established vaccine has no benefits.
Which doesn’t imply overwhelming evidence, though. Just enough evidence.
Agreed; I probably wouldn’t have said “overwhelming evidence”. But I do think there are still large gains to be made by vaccinating against more diseases, like, say, strep.
Revelation: The point of diminishing returns we would (in an ideal reach) is where health benefits are proportional to research dollars. Once a vaccine is researched, health benefits should be positive. However, variation, like the variation between regions, means that there are cases where an established vaccine has no benefits.